Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Terminated 1Active not recruiting 1

Sponsor Class

NIH 2

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 2

Conditions

Squamous Cell Carcinoma of Head and Neck 22Oropharyngeal Neoplasms 14Mouth Neoplasms 9Laryngeal Neoplasms 9Carcinoma 9Hypopharyngeal Neoplasms 8Nasopharyngeal Carcinoma 6Lymphoid Interstitial Pneumonia 4Head and Neck Neoplasms 4Salivary Gland Neoplasms 3Tongue Neoplasms 2Stomatitis 1Stage II Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7 1Stage I Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7 1Paranasal Sinus Neoplasms 1Papillomavirus Infections 1Pancreatic Neoplasms 1Lymphatic Metastasis 1Locally Advanced Hypopharyngeal Carcinoma 1Gallbladder Neoplasms 1Epstein-Barr Virus Infections 1Carcinoma, Squamous Cell 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Cetuximab 16Cisplatin 15Radiotherapy, Intensity-Modulated 10Radiotherapy 6Docetaxel 6Erlotinib Hydrochloride 5Fluorouracil 4Everolimus 4Carboplatin 4Sorafenib 3Radiation 3Paclitaxel 3Fluorodeoxyglucose F18 3Chemotherapy, Adjuvant 3Biopsy 3Albumin-Bound Paclitaxel 3130-nm albumin-bound paclitaxel 3Taxes 2Sirolimus 2Radiotherapy, Conformal 2Psychiatric Rehabilitation 2Platinum 2Photochemotherapy 2Microarray Analysis 2Magnetic Resonance Spectroscopy 2Immunohistochemistry 2Gene Expression Profiling 2Drug Therapy 2Celecoxib 2Bevacizumab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Tongue Neoplasms × Platinum × Head & Neck × Clear all
NCT00588770 2026-05-29

Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

National Cancer Institute (NCI)

Phase 3 Active not recruiting
403 enrolled 10 charts
Head & Neck

Lymphoid Interstitial Pneumonia, Squamous Cell Carcinoma of Head and Neck, Salivary Gland Neoplasms, Tongue Neoplasms

NCT02196168 2017-05-03

Cisplatin With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

National Cancer Institute (NCI)

Phase 2 Terminated
6 enrolled 9 charts
Head & Neck

Lymphoid Interstitial Pneumonia, Squamous Cell Carcinoma of Head and Neck, Tongue Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡